Abstract

Adenovirotherapy delivering cross-hybrid IgGA Fc engineering PD-L1 inhibitors for enhanced cancer immunotherapy

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Advancing together and moving forward: Combination gene and cellular immunotherapies
Prasad S Adusumilli ... Waseem Cheema
Molecular Therapy - Oncolytics | VOL. 25
Prasad S Adusumilli, et. al.Prasad S Adusumilli ... Waseem Cheema
30 May 2022
A Critical Role for Type I IFN–dependent NK Cell Activation in Innate Immune Elimination of Adenoviral Vectors In Vivo
Xiaopei Huang ... Jiangao Zhu
Molecular Therapy | VOL. 16
Xiaopei Huang, et. al.Xiaopei Huang ... Jiangao Zhu
01 Jul 2008
Silencing a Killer Among Us: Ethanol Impairs Immune Surveillance of Activated Stellate Cells by Natural Killer Cells
Gavin E Arteel
Gastroenterology | VOL. 134
Gavin E ArteelGavin E Arteel
31 Dec 2008
Infection-Induced Regulation of Natural Killer Cells by Macrophages and Collagen at the Lymph Node Subcapsular Sinus
Nico Van Rooijen ... David H Raulet
Cell Reports | VOL. 2
Nico Van Rooijen, et. al.Nico Van Rooijen ... David H Raulet
01 Jul 2012
View more papers

More From: Molecular Therapy - Oncolytics

Paper Title
Journal
Date
Author
Thank you to our 2023 reviewers
-
Molecular Therapy - Oncolytics | VOL. 31
--
01 Dec 2023
Gaining insights into virotherapy with canine models
Lee-Hwa Tai ... Jacob L Léger
Molecular Therapy - Oncolytics | VOL. 31
Lee-Hwa Tai, et. al.Lee-Hwa Tai ... Jacob L Léger
01 Dec 2023
Targeting mesothelin in cancer
Cem Elbi
Molecular Therapy - Oncolytics | VOL. 31
Cem ElbiCem Elbi
01 Dec 2023
New advances in cancer therapy targeting TGF-β signaling pathways
Ling Ma ... Minyue Shou
Molecular Therapy - Oncolytics | VOL. 31
Ling Ma, et. al.Ling Ma ... Minyue Shou
01 Dec 2023
View more papers